Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2118)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
101
Price
$331.93
Total Value
$33.52K
Shares Held After
25,223
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
87
Price
$330.85
Total Value
$28.78K
Shares Held After
25,324
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
182
Price
$329.71
Total Value
$60.01K
Shares Held After
25,411
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
107
Price
$328.71
Total Value
$35.17K
Shares Held After
25,593
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
353
Price
$327.67
Total Value
$115.67K
Shares Held After
25,700
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
421
Price
$326.81
Total Value
$137.59K
Shares Held After
26,053
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
277
Price
$325.63
Total Value
$90.20K
Shares Held After
26,474
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
97
Price
$324.65
Total Value
$31.49K
Shares Held After
26,751
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
50
Price
$323.62
Total Value
$16.18K
Shares Held After
26,848
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
578
Price
$70.46
Total Value
$40.73K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,322
Price
$69.80
Total Value
$1.07M
Shares Held After
768,358
% of Holdings
2.0%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
4,051
Price
$1.43
Total Value
$5.79K
Shares Held After
240,755
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,100
Price
$69.20
Total Value
$283.71K
Shares Held After
783,680
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
2,590
Price
$1.43
Total Value
$3.70K
Shares Held After
244,806
% of Holdings
1.0%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
4,433
Price
$1.43
Total Value
$6.34K
Shares Held After
247,396
% of Holdings
1.8%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
1,163
Price
$1.43
Total Value
$1.66K
Shares Held After
251,829
% of Holdings
0.5%
Vanda Pharmaceuticals Inc. (VNDA)
Moran Kevin Patrick — SVP, CFO & Treasurer
Shares
42,442
Price
$8.27
Total Value
$350.82K
Shares Held After
411,380
% of Holdings
9.4%
Vanda Pharmaceuticals Inc. (VNDA)
Williams Timothy — SVP & General Counsel
Shares
42,434
Price
$8.27
Total Value
$350.76K
Shares Held After
377,450
% of Holdings
10.1%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
66,363
Price
$28.14
Total Value
$1.87M
Shares Held After
793
% of Holdings
98.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
4,090
Price
$27.51
Total Value
$112.50K
Shares Held After
67,156
% of Holdings
5.7%
Vanda Pharmaceuticals Inc. (VNDA)
Wijkstrom Joakim — SVP, Chief Marketing Officer
Shares
30,800
Price
$8.27
Total Value
$254.59K
Shares Held After
333,469
% of Holdings
8.5%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
3,048
Price
$89.66
Total Value
$273.28K
Shares Held After
122,029
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,055
Price
$88.50
Total Value
$93.37K
Shares Held After
125,077
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,510
Price
$87.75
Total Value
$132.50K
Shares Held After
126,132
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,107
Price
$89.66
Total Value
$99.25K
Shares Held After
77,729
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
383
Price
$88.50
Total Value
$33.90K
Shares Held After
78,836
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
549
Price
$87.75
Total Value
$48.18K
Shares Held After
79,219
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
4,113
Price
$89.66
Total Value
$368.76K
Shares Held After
237,483
% of Holdings
1.7%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,424
Price
$88.50
Total Value
$126.02K
Shares Held After
241,596
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
2,039
Price
$87.75
Total Value
$178.92K
Shares Held After
243,020
% of Holdings
0.8%
Progyny, Inc. (PGNY)
Swartz Allison — EVP, GC
Shares
2,199
Price
$17.27
Total Value
$37.98K
Shares Held After
97,378
% of Holdings
2.2%
Annexon, Inc. (ANNX)
Overdorf Michael — EVP & CHIEF BUSINESS OFFICER
Shares
4,339
Price
$5.42
Total Value
$23.52K
Shares Held After
182,625
% of Holdings
2.3%
Annexon, Inc. (ANNX)
Yednock Ted — EVP & CHIEF INNOVATION OFFICER
Shares
5,566
Price
$5.42
Total Value
$30.17K
Shares Held After
154,161
% of Holdings
3.5%
Annexon, Inc. (ANNX)
Dananberg Jamie — CHIEF MEDICAL OFFICER
Shares
5,820
Price
$5.43
Total Value
$31.60K
Shares Held After
123,582
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,052
Price
$90.13
Total Value
$905.99K
Shares Held After
675,341
% of Holdings
1.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
71,814
Price
$90.13
Total Value
$6.47M
Shares Held After
3,902,667
% of Holdings
1.8%
uniQure N.V. (QURE)
Potts Jeannette — Chief Legal Officer
Shares
8,578
Price
$9.95
Total Value
$85.35K
Shares Held After
106,495
% of Holdings
7.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
29,282
Price
$14.48
Total Value
$424.12K
Shares Held After
3,334,683
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
7,909
Price
$14.52
Total Value
$114.85K
Shares Held After
165,638
% of Holdings
4.6%
Annexon, Inc. (ANNX)
Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER
Shares
5,565
Price
$5.42
Total Value
$30.16K
Shares Held After
170,700
% of Holdings
3.2%
Annexon, Inc. (ANNX)
ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER
Shares
5,894
Price
$5.43
Total Value
$32.00K
Shares Held After
180,093
% of Holdings
3.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
29,282
Price
$14.47
Total Value
$423.76K
Shares Held After
3,334,616
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Bedrosian Camille L — Chief Medical Officer
Shares
6,461
Price
$14.58
Total Value
$94.21K
Shares Held After
169,295
% of Holdings
3.7%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
6,844
Price
$14.52
Total Value
$99.38K
Shares Held After
134,430
% of Holdings
4.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
6,615
Price
$18.25
Total Value
$120.72K
Shares Held After
166,912
% of Holdings
3.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
1,472
Price
$18.26
Total Value
$26.88K
Shares Held After
166,912
% of Holdings
0.9%
MCKESSON CORP (MCK)
Lau Michele — EVP and Chief Legal Officer
Shares
2,725
Price
$990.00
Total Value
$2.70M
Shares Held After
3,247
% of Holdings
45.6%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
9,100
Price
$42.49
Total Value
$386.66K
Shares Held After
642,540
% of Holdings
1.4%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,900
Price
$41.73
Total Value
$246.21K
Shares Held After
651,640
% of Holdings
0.9%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
365
Price
$201.18
Total Value
$73.43K
Shares Held After
156,607
% of Holdings
0.2%
Showing 1751–1800 of 2118 transactions (page 36 of 43)